BGL Announces Growth Equity Investment in Azzur Group by Baird Capital

Brown Gibbons Lang & Company (BGL), a leading investment banking and financial advisory firm, is pleased to announce the closing of a growth equity investment in Azzur Group (Azzur) by Baird Capital. BGL’s Healthcare & Life Sciences team initiated the transaction and acted as the exclusive financial advisor to Azzur. The specific terms of the transaction were not disclosed.

From Discovery to Delivery™, Azzur Group provides full life-cycle solutions across the GxP spectrum. From its Azzur Cleanrooms on Demand™ facilities to its laboratories, training centers, and consulting offices across the nation, Azzur helps pharma, biotech, and medical device companies start, scale, and sustain their businesses. Azzur’s fastest-growing segment, Azzur Cleanrooms on Demand™, provides early-phase life science companies a hybrid alternative to traditional manufacturing cGMP scale-up challenges. Baird Capital’s investment will accelerate the growth of this novel offering while augmenting core capabilities in advisory, consulting, laboratory, and training services.

Baird Capital makes venture capital, growth equity, and private equity investments in strategically targeted sectors around the world. Having invested in more than 320 companies over its history, Baird Capital partners with entrepreneurs and, leveraging its executive networks, strives to build exceptional companies.

Read our full, joint press release with Azzur & Baird Capital via PR Newswire.